| ||
| European court ruling on abortion Irish Times Anyone who has been through treatment for cancer or has a relative who has been through it, knows how gruelling that is. When one adds the burden of ... See all stories on this topic » | ||
| ||
| Your mail: Wonderful gift Alexandria Town Talk My wife just finished treatment for breast cancer and the insurance did not cover all of the expenses. I received a call at work from Mark that Thursday ... See all stories on this topic » | ||
| Rein-In The Regulators Germantown Now (blog) The FDA (Federal Drug Administration) just ruled that Avastin will no longer be classified as a permissible drug in the treatment of breast cancer at almost ... See all stories on this topic » | ||
| HOLX, AINV, ALTH, MIPS, MPET - Stocks to watch at NASDAQ Wall Street Bay The Company's business segments are focused on breast health, diagnostics, GYN surgical and skeletal health. It offers products in five categories: Breast ... See all stories on this topic » |
| ||
| HALO, PWRM, CEDU, ORFG, VVUS - DoubleInStocks.com Stock Report ... By The Editor This innovative subcutaneous alternative is expected to take less than five minutes to administer and should allow patients with HER2-positive breast cancer to receive their treatment in their physician's office or potentially at home ... Double In Stocks - http://doubleinstocks.com/ |
| ||
| Friends With Cancer - Breast Cancer Blog I do not have breast cancer, but it makes small difference, in the treatments and years and our lives between the three month scans. ... www.everydayhealth.com/blog/.../friends-with-cancer/?...id... | ||
| FDA Revokes Approval for Breast Cancer Drug | Lifescript.com There's no question the risks of Avastin can be severe, and a course of treatment is expensive – up to $88000. Breast cancer patients on Avastin are at ... www.lifescript.com/.../FDA_Revokes_Approval_for_Breast_C... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment